Ebenezer O. Sackey

Array ( [id] => 4746415 [patent_doc_number] => 20080091017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Polymorphic form B2 of ziprasidone base' [patent_app_type] => utility [patent_app_number] => 11/999294 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7006 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20080091017.pdf [firstpage_image] =>[orig_patent_app_number] => 11999294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746417 [patent_doc_number] => 20080091019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Polymorphic form B2 of Ziprasidone base' [patent_app_type] => utility [patent_app_number] => 11/999369 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7007 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20080091019.pdf [firstpage_image] =>[orig_patent_app_number] => 11999369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746416 [patent_doc_number] => 20080091018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Polymorphic form B2 of ziprasidone base' [patent_app_type] => utility [patent_app_number] => 11/999339 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7005 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20080091018.pdf [firstpage_image] =>[orig_patent_app_number] => 11999339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270432 [patent_doc_number] => 08211937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => '7-pyrollyl 9-aminoacyl tetracycline compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/949392 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5799 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11949392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602039 [patent_doc_number] => 20100048900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'AGENT FOR TREATMENT OF VASCULAR LEAKS' [patent_app_type] => utility [patent_app_number] => 12/516889 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2273 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048900.pdf [firstpage_image] =>[orig_patent_app_number] => 12516889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827131 [patent_doc_number] => 20080125484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Synthetic Lactone Formulations and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/947077 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7783 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125484.pdf [firstpage_image] =>[orig_patent_app_number] => 11947077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515407 [patent_doc_number] => 08039479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Compounds and compositions as protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/943436 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34407 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039479.pdf [firstpage_image] =>[orig_patent_app_number] => 11943436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899846 [patent_doc_number] => 20080119460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'ALLOSTERIC MODULATORS OF THE A1 ADENOSINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/938514 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27642 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119460.pdf [firstpage_image] =>[orig_patent_app_number] => 11938514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4826932 [patent_doc_number] => 20080125438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'ALLOSTERIC MODULATORS OF THE A1 ADENOSINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/938465 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27648 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125438.pdf [firstpage_image] =>[orig_patent_app_number] => 11938465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401851 [patent_doc_number] => 20100179178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'PYRIMIDINE DERIVATIVES AS POSH AND POSH-AP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/312416 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20590 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179178.pdf [firstpage_image] =>[orig_patent_app_number] => 12312416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965806 [patent_doc_number] => 20080108626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'PYRAZOLE-AMINE COMPOUNDS USEFUL AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/931309 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13990 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108626.pdf [firstpage_image] =>[orig_patent_app_number] => 11931309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765859 [patent_doc_number] => 20080177071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor' [patent_app_type] => utility [patent_app_number] => 11/976839 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3616 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177071.pdf [firstpage_image] =>[orig_patent_app_number] => 11976839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697873 [patent_doc_number] => 20080220057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'THERAPEUTIC COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/927418 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8567 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220057.pdf [firstpage_image] =>[orig_patent_app_number] => 11927418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574789 [patent_doc_number] => 07825095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics' [patent_app_type] => utility [patent_app_number] => 11/923486 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 30722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825095.pdf [firstpage_image] =>[orig_patent_app_number] => 11923486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265825 [patent_doc_number] => 20090118510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Dark coloured azo dyes' [patent_app_type] => utility [patent_app_number] => 11/975583 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5933 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118510.pdf [firstpage_image] =>[orig_patent_app_number] => 11975583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599796 [patent_doc_number] => 07977338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Phenylacetamides being FLT3 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/445545 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26179 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977338.pdf [firstpage_image] =>[orig_patent_app_number] => 12445545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693132 [patent_doc_number] => 20080085903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/870067 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3001 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085903.pdf [firstpage_image] =>[orig_patent_app_number] => 11870067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693234 [patent_doc_number] => 20080086005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/870090 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3001 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20080086005.pdf [firstpage_image] =>[orig_patent_app_number] => 11870090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846448 [patent_doc_number] => 20080182856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/870108 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3001 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182856.pdf [firstpage_image] =>[orig_patent_app_number] => 11870108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598658 [patent_doc_number] => 20100048717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'CATHEPSIN B INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/442757 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048717.pdf [firstpage_image] =>[orig_patent_app_number] => 12442757 [rel_patent_id] =>[rel_patent_doc_number] =>)